News

Turmoil in the financial markets is having a disproportionate impact on biotech – and coupled with extra caution from regulators, is threatening innovation.

Alternative Dispute Resolution can help keep litigation costs down and reach a speedy conclusion to a dispute.

Brussels is abuzz with speculation that Europe’s fragmented, costly and complex patent regime is about to reform – aided by advances in machine translation. But support is not unanimous.

ICAMS, the Interdisciplinary Centre for Advanced Materials Simulation established with a €24 million contribution from leading German firms, has been officially opened by the Ruhr University.

South African scientists will gain access to European molecular biology research through the European Molecular Biology Organization after their government signed a cooperation agreement.

Luxembourg is to invest €140 million over five years in a bid to become a centre of excellence in molecular medicine, partnering with three leading US institutions to help achieve the aim.